Upper respiratory infection
Conditions
Interventions
Treatment group:The rapid detection platform of Accunome nucleic acid was used to quickly obtain the pathogen detection report and guide the clinical medication adjustment in time.
Control group:The routine molecular platform was used to detect respiratory viruses, and the clinician made medication and adjustment according to the test report
Sponsors
Second Hospital of Tianjin Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Be at least 18 years old. 2. Hospitalized patients. 3. Accompanied by symptoms of respiratory infection, pathogen testing should be performed according to clinical judgment (and specific indications for clinical confirmation). 4. Informed consent of patient or legal guardian.
Exclusion criteria
Exclusion criteria: 1. Patients using hormone drugs 2. Rheumatoid arthritis patients 3. Patients with severe diabetes 4. Patients with severe hepatic and renal insufficiency 5. Patients with immune insufficiency
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The timing and adjustment ratio from patient admission to using antimicrobials( including antibiotics and antivirals) according to viral test results ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Compare the difference in reporting time between the DXcellence12 platform and the conventional PCR platform in the laboratory.;Compare the effects of the DXcellence12 platform and the conventional PCR platform in the laboratory on the treatment outcome and cost.;The differences (detection rate, sensitivity and specificity) between the DXcellence12 platform and the conventional PCR platform were compared.; | — |
Countries
China
Contacts
Public ContactYang Cao
Second Hospital of Tianjin Medical University
Outcome results
None listed